Acidic and neutral glycosphingolipids were isolated from a human gastric adenocarcinoma, and binding of Helicobacter pylori to the isolated glycosphingolipids was assessed using the chromatogram binding assay. The isolated glycosphingolipids were characterized using fast atom bombardment mass spectrometry and by binding of antibodies and lectins. The predominating neutral glycosphingolipids were found to migrate in the di-to tetraglycosylceramide regions as revealed by anisaldehyde staining and detection with lectins. No binding of H. pylori to these compounds was obtained. The most abundant acidic glycosphingolipids, migrating as the GM3 ganglioside and sialylneolactotetraosylceramide, were not recognized by the bacteria. Instead, H. pylori selectively interacted with slowmigrating, low abundant gangliosides not detected by anisaldehyde staining. Binding-active gangliosides were isolated and characterized by mass spectrometry, proton nuclear magnetic resonance, and lectin binding as sialylneolactohexaosylceramide (NeuAcα3Galβ4GlcNAcβ3Gal-β4GlcNAcβ3Galβ4Glcβ1Cer) and sialyl-neolactooctaosylceramide (NeuAcα3Galβ4GlcNAcβ3Galβ4GlcNAcβ3Gal-β4GlcNAcβ3Galβ4Glcβ1Cer).
Introduction
Helicobacter pylori is a human-specific pathogen found in the gastric mucus or attached to the gastric epithelium (Warren and Marshall, 1983) . Half of the world's adult population is infected by this organism, but most of those infected remain asymptomatic, with clinical symptoms occurring in only 10-20% of infected individuals. In the event of clinical symptoms appearing H. pylori is known to be the etiologic agent in the development of chronic active gastritis and peptic ulcer disease and is a risk factor in the development of gastric cancer and mucosa-associated lymphoid tissue (MALT) lymphoma. A recent report even implicates H. pylori infection with Sudden Infant Death Syndrome (Kerr et al., 2000) .
Attachment of a microbe to a cell surface receptor on the target tissue is considered an essential step in the initiation, establishment, and maintenance of infection. As a result great interest has been shown in the elucidation and identification of potential host receptors, the majority of which appear to be glycoconjugates. Glycoconjugates exhibit a characteristic and specific pattern of expression, which is dependent on the animal species, individual, and cell type, thus explaining the phenomenon of tropism of infection. An understanding of the interaction between the microbe and the carbohydrate moiety of such glyocconjugates offers an alternate mode of treatment of infection in the form of anti-adhesive therapy. Anti-adhesive therapy is particularly attractive in the case of H. pylori infection for a number of reasons. Though H. pylori infection can be combated by antibiotic treatment, resistant strains are emerging (Xia et al., 1996; Vakil et al., 1998) , creating a need for an alternate form of treatment. One alternative to antibiotic therapy is vaccination. However, development of a suitable vaccine has been hindered by the need for a nontoxic adjuvant and the degree of protection offered (reviewed in Banerjee and Michetti, 1999) . Anti-adhesive therapy is a good second alternative method to combat infection with H. pylori because it neither promotes the emergence of resistant strains nor gives rise to the hurdles presented by vaccine development. Among potential receptors described for H. pylori are N-acetylneuraminyllactose (Evans et al., 1988) , lactosylceramide (Ångström et al., 1998) , sialic acid-containing glycosphingolipids and polyglycosylceramides (Miller-Podraza et al., 1996) , sulfatide (Saitoh et al., 1991; Kamisago et al., 1996) , Lewis b blood group epitope (Borén et al., 1993) , and gangliotriaosylceramide and gangliotetraosylceramide (Gold et al., 1993) . Other potential receptors described for H. pylori include heparan sulfate (Ascencio et al., 1993) and phosphatidylethanolamine (Lingwood et al., 1992) .
A number of different approaches have been employed in the elucidation of target tissue receptors for H. pylori. A combination of in situ analysis of the binding of H. pylori to human gastric surface mucosal cells, blocking of binding by preincubation of bacteria with neoglycoconjugates, and the binding of H. pylori to glycoconjugates immobilized on protein blots were used to reveal the binding of H. pylori to the Le b antigen (Borén et al., 1993) . In another study, binding of H. pylori to glycolipids obtained from human gastric mucosa separated on thin-layer plates was reported (Saitoh et al., 1991) . The aim of the present study was to characterize the glycosphingolipids of a human gastric adenocarcinoma, which is derived from the human gastric epithelium, with particular interest in those components with H. pylori-binding activity. We show here that the major acidic glycosphingolipids of human adenocarcinoma, the GM3 ganglioside and sialyl-neolactotetraosylceramide, were not recognized by the bacteria. Instead, H. pylori bound to low abundant, slow-migrating, sialic acid-containing glycosphingolipids, characterized as sialyl-neolactohexaosylceramide and sialyl-neolactooctaosylceramide. 1 To whom correspondence should be addressed
Results

Isolation of glycosphingolipids from human gastric adenocarcinoma
From approximately 80 g of starting material, 500 mg of total acidic and 430 mg of total neutral glycosphingolipids were obtained. The sialic acid and sphingosine content of the total acidic glycosphingolipid fraction were 402 and 457 nmol per g dry weight, respectively. The sphingosine content of the total neutral glycosphingolipid fraction was 579 nmol per g dry weight. Anisaldehyde staining of the total neutral glycosphingolipid fraction (Figure 1, lane 4) revealed the presence of three major glycosphingolipids. The dominating component migrated as the lactosylceramide component in the neutral glycosphingolipid fraction of human erythrocytes (lane 1). Two other components of equal intensity were also observed. The faster-migrating of these migrated as globotriaosylceramide (lane 2), and the slower migrated as globotetraosylceramide (lane 3). A number of low abundant, slow-migrating components below the tetraglycosylceramide region were also observed. The dominating glycosphingolipid of the total acidic fraction (lane 5) migrated at the level of the GM3 ganglioside reference (lane 6). Two minor components, of which the fastermigrating one migrated as sialyl-neolactotetraosylceramide (lane 7), were also observed.
Binding of H. pylori to glycosphingolipids from human gastric adenocarcinoma
To investigate the presence of glycosphingolipids with H. pylori binding activity, the binding of four H. pylori strains to both the crude total acidic and the total neutral glycosphingolipid fractions from human gastric adenocarcinoma was investigated. The binding of H. pylori to the crude total acidic glycosphingolipid fraction obtained from human gastric adenocarcinoma was initially tested in parallel with the crude total acidic glycosphingolipid fractions of human gall bladder adenocarcinoma and human neutrophils (Figure 2) . Thereby, binding of the bacteria to the total acidic glycosphingolipid fraction of human gastric adenocarcinoma, along with binding to the acidic glycosphingolipid fraction of human gallbladder adenocarcinoma, and human neutrophils was observed ( Figure 2B , lanes 2-4), whereas no binding to the GM3 ganglioside (lane 1) occurred. In all cases the bacteria bound to slow-migrating gangliosides migrating below the GM3 reference and sialylneolactotetraosylceramide of human neutrophils, and which were not detected by the chemical stain (Figure 2A ). Of the strains tested, only strains CCUG 17874 and S-032 bound the acidic glycosphingolipids from human gastric adenocarcinoma; no binding of strains CCUG 17875 or 26695 was obtained.
None of the four strains tested bound to the total neutral glycosphingolipid fraction (not shown); therefore the neutral fraction will not be discussed further.
Purification of acidic glycosphingolipids from human gastric adenocarcinoma
To purify the acidic glycosphingolipids of the human gastric adenocarcinoma, the crude total acidic fraction was acetylated and separated on a silicic acid column followed by deacetylation, Iatrobeads column chromatography, and final purification by high-performance liquid chromatography (HPLC). The fractions obtained were stained by anisaldehyde to select glycosphingolipid-containing fractions and subsequently tested for H. pyloribinding activity using the chromatogram binding assay. Fractions were pooled according to their mobility on thin-layer Gangliosides of the total acidic fraction of human gastric adenocarcinoma as detected by anisaldehyde staining (A) and by autoradiography after binding of 35 S-labeled H. pylori strain CCUG 17874 (B). The glycosphingolipids were separated on thin-layer plates using chloroform:methanol:water (60:35:8, by volume) as solvent system, and binding assays were carried out as described under Materials and methods. Autoradiography was for 12 h. Lane 1: GM3 ganglioside (NeuAcα3Galβ4Glc41Cer) of human brain, 4 µg; lane 2: total acidic glycosphingolipid fraction of human gall bladder adenocarcinoma, 40 µg; lane 3: total acidic glycosphingolipid fraction of human gastric adenocarcinoma, 80 µg; lane 4: total acidic glycosphingolipid fraction of human neutrophil granulocytes, 40 µg. The bands marked I and II indicate the migration of GM3 ganglioside and SPG respectively, and bands marked with an X are nonglycosphingolipid contaminants.
chromatograms and H. pylori-binding activity, giving rise to four fractions, designated fractions I-IV. Fractions I and II weighed approximately 1 mg each, but only 100 µg of both fractions III and IV was obtained. Fraction I migrated in the GM3 region, fraction II in the sialyl-neolactotetraosylceramide region, and fractions III and IV were more slow-migrating ( Figure 3A , lanes 2-5).
Binding of H. pylori to purified gangliosides from human gastric adenocarcinoma
To determine which of the four fractions contained H. pylori binding activity, binding assays using H. pylori strain CCUG 17874 were carried out. No binding of H. pylori to fractions I and II was observed ( Figure 3B , lanes 2 and 3), while the bacteria bound to two components in both fractions III and IV ( Figure 3B , lanes 4 and 5). A comparison of lanes 1, 4, and 5 ( Figure 3A ) with the corresponding lanes in Figure 3B shows that binding in all three cases is to slow-migrating components, two of which are not detected by chemical staining. In addition, binding of H. pylori to the references sialyl-neolactohexaosylceramide and sialyl-neolactooctoaosylceramide ( Figure 3 , lane 7), which comigrated with the H. pyloribinding compounds in fractions III and IV, was observed.
Negative ion FAB-MS of the ganglioside fractions isolated from human gastric adenocarcinoma
Fast atom bombardment mass spectrometry (FAB-MS) in the negative mode was used for initial characterization of the four ganglioside fractions isolated from human gastric adenocarcinoma. In the spectrum of fraction I (not shown) characteristic molecular ions at m/z 1152, 1236, and 1252 indicated a glycosphingolipid with one NeuAc and two Hex combined with d18:1-16:0, d18:1-22:0, and d18:1-h22:0 ceramides, respectively. The latter species constituted the dominating ceramide species in this fraction. Sequence ions obtained from the molecular ion at m/z 1252 were seen at m/z 961 (M-NeuAc) and m/z 799 (M-NeuAc-Hex). A peak at m/z 1467, which is the molecular ion of a glycosphingolipid with one NeuAc, one HexNAc, and two Hex, combined with d18:1-24:0 ceramide, was also observed.
The mass spectrum of fraction II (not shown) had molecular ions at m/z 1630 and 1602, which are characteristic of a glycosphingolipid with one NeuAc, one HexNAc, and three Hex, with d18:1-24:0 and d18:1-22:0 ceramides, respectively. In the spectrum of fraction IV ( Figure 4B ) six molecular ions were observed. The molecular ions at m/z 1882 and 1992 corresponded to NeuAc-Hex-HexNAc-Hex-HexNAc-Hex-Hex sequence with either d18:1-16:0 or d18:1-24:1 ceramides, as discussed, while the molecular ions at m/z 2010 and 2028 corresponded to . The gangliosides were chromatographed using chloroform:methanol:water (60:35:8, by volume) as solvent system, and after drying rechromatographed once using the same solvent system. The binding assays were done as described under Materials and methods. The arrow marks the level on the thin-layer chromatogram plate at which the sample was applied. Lane 1: total acidic glycosphingolipid fraction of human gastric adenocarcinoma, 80 µg; lane 2: fraction I isolated from human gastric adenocarcinoma, 4 µg; lane 3: fraction II isolated from human gastric adenocarcinoma, 2 µg; lane 4: fraction III isolated from human gastric adenocarcinoma, 2 µg; lane 5: fraction IV isolated from human gastric adenocarcinoma, 2 µg; lane 6: reference sialyl-neolactotetraosylceramide (NeuAcα3Galβ4GlcNAcβ3Galβ4Glcβ1Cer) of human erythrocytes, 4 µg; lane 7: reference sialyl-neolactohexaosylceramide (NeuAcα3Galβ4GlcNAc-β3Galβ4GlcNAcβ3Galβ4Glcβ1Cer) and sialyl-neolactooctaosylceramide (NeuAcα3Galβ4GlcNAcβ3Galβ4GlcNAcβ3Galβ4GlcNAcβ3Galβ4Glcβ1Cer) of human erythrocytes 4 µg; lane 8: reference sialyl-Le a hexaglycosylceramide (NeuAcα3Galβ3(Fucα4)GlcNAcβ3Galβ4Glcβ1Cer) of human gallbladder adenocarcinoma, 4 µg. Autoradiography was for 12 h. The apparent bands observed in Figure 3C lanes 1 and 4 are artfacts. the same carbohydrate sequence attached to d18:1-h24:0 and t18:0-h24:0 ceramides, respectively. The molecular ions at m/z 2247 and 2358 represented an analogous compound with NeuAc-Hex-HexNAc-Hex-HexNAc-Hex-HexNAc-Hex-Hex sequence attached to d18:1-16:0 and d18:1-24:1 ceramides. A fragment ion at m/z 1906 corresponding to m/z 2358-NeuAcHex was also observed. A series of peaks were also observed between m/z 1906 and 1993. However, these could not be accurately assigned due to poor resolution within this region.
Thus a ganglioside with NeuAc-Hex-HexNAc-Hex-HexNAcHex-Hex sequence was indicated by mass spectrometry of H. pylori-binding fraction III. The same ganglioside sequence was present in the spectrum of H. pylori-binding fraction IV, and in addition a ganglioside with NeuAc-Hex-HexNAc-HexHexNAc-Hex-HexNAc-Hex-Hex sequence was demonstrated.
Proton NMR of fraction III isolated from human gastric adenocarcinoma
Mass spectrometry data indicate that fraction III contains a glycosphingolipid with the sequence NeuAc-Hex-HexNAcHex-HexNAc-Hex-Hex, pointing to the ganglioside sialylneolactohexaosylceramide. However, the 600 MHz proton nuclear magnetic resonance (NMR) spectrum of fraction III ( Figure 5 ) clearly reveals the presence of two molecular species with approximate relative intensities 60/40.
A comparison with the reference compound sialyl-Le a (NeuAcα3Galβ3(Fucα4)GlcNAcβ3Galβ4Glcβ1Cer) purified from gallbladder adenocarcinoma (unpublished) indicates that the dominating species is identical to this glycosphingolipid (ppm values are given in parentheses). Thus the α-anomeric signal at 4.78 (4.76) ppm suggests the presence of a Fucα4 residue as does the signal at 4.64 (4.66) ppm attributable to the H-5 proton of the same residue. The β-anomeric signal seen at 4.69 (4.69) ppm is indicative of a GlcNAcβ3 residue, whereas the β-anomeric signal at 4.36 (4.33) ppm most likely is due to an internal Galβ3. The anomeric Galβ4 signal is seen at 4.27 (4.27) ppm, and the Glcβ1 signal is found at 4.16 (4.16) ppm. In addition, the resonance due to the H3 eq proton of NeuAcα3 is found at 2.75 (2.77) ppm. Furthermore, in the N-acetyl region the two methyl signals seen at 1.87 (1.89) ppm and 1.83 (1.81) ppm again reveal the presence of a GlcNAc residue and a NeuAc residue, respectively.
The signals from the minor species most likely corresponds to sialyl-neolactohexaosyl ceramide (NeuAcα3Galβ4GlcNAc-β3Galβ4GlcNAcβ3Galβ4Glcβ1Cer) as suggested by mass spectrometric data and earlier NMR data (given in parentheses) on the pure compound (Stroud et al., 1996) . The two partially overlapping GlcNAcβ3 anomeric signals from sialylneolactohexaosylceramide are expected around 4.64 (4.64) ppm, appearing as a triplet, thus overlapping also with the Fucα4 H-5 proton of sialyl-Le a . The two internal Galβ4 anomeric signals are expected around 4.25 (4.26) ppm, while the penultimate Galβ4 and Glcβ1 anomeric signals are seen at 4.22 (4.20) and 4.20 (4.19) ppm, respectively. The resonance due to the H-3 eq proton of NeuAcα3 is found at 2.75 (2.75) ppm, overlapping with the corresponding residue of sialyl-Le a . However, the methyl resonances originating from the N-acetyl moieties of NeuAcα3 and the two GlcNAcβ3 are clearly separated from the corresponding sialyl-Le a signals and are Fig. 4 . Negative ion FAB mass spectra of fraction III (A) and fraction IV (B) isolated from human gastric adenocarcinoma. Fractions were dissolved in dimethyl sulfoxide, and FAB-MS was carried out in the negative mode using Xe atoms (6 keV), triethanolamine as matrix, and a resolution of 1000. Two spectra were collected, one using an acceleration voltage of 10 kV (A) and the second using an acceleration voltage of 8 kV (B). For spectrum B a range of 1500-2500 mass units was scanned and data collected for 15 min. Only that part of the spectrum ranging from m/z 1800 to 2350 is shown here. found at 1.89 (1.89) ppm and 1.81 (1.81) ppm, respectively. Due to insufficient material it was not possible to perform NMR analysis on fraction IV.
Binding of Solanum tuberosum lectin to gangliosides of human gastric adenocarcinoma
To further characterize the H. pylori-binding compounds in fractions III and IV, binding assays using S. tuberosum lectin PL-I, which binds to sialic acid-terminated glycosphingolipids carrying an internal dimeric Galβ4GlcNAcβ sequence (Ciopraga et al., 2000) , were subsequently carried out. The lectin bound to the total acidic fraction of human gastric adenocarcinoma ( Figure 3D , lane 1), to fractions III and IV (lanes 4 and 5) and to the references sialyl-neolactohexaosylceramide and sialyl-neolactooctaosylceramide (lane 7). Indeed, the binding pattern of the S. tuberosum lectin was identical to the binding patterns obtained with H. pylori strains CCUG 17874 ( Figure 3B ) and S-032 (not shown).
Binding of Erythrina corallodendron lectin to desialylated gangliosides of human gastric adenocarcinoma
The lectin from E. corallodendron binds to glycosphingolipids with terminal Galβ4GlcNAcβ and Fucα2Galβ4GlcNAcβ sequences (Teneberg et al., 1994) . Binding of 125 I-labeled E. corallodendron lectin to the de-sialylated fractions III and IV of human gastric adenocarcinoma is shown in Figure 6 . Thus desialylation of fraction III resulted in a compound with E. corallodendron-binding activity, migrating in the hexaglycosylceramide region (lane 2), while the desialylated fraction IV (lane 4) had two compounds with E. corallodendronbinding activity, migrating as hexa-and octaglycosylceramides, respectively.
Binding of monoclonal antibody CA 19-9 to gangliosides of human gastric adenocarcinoma
Because the proton NMR analysis suggested the presence of sialyl-Le a in fraction III binding by the monoclonal antibody CA 19-9, which recognizes the sialyl-Le a epitope (Magnani et al., 1982) was tested. However, the monoclonal antibody bound only to the reference sialyl-Le a hexaglycosylceramide ( Figure 3C , lane 8; Figure 7C , lanes 2 and 3), while no binding to the total acidic fraction of human gastric adenocarcinoma or to fractions I-IV isolated there from ( Figure 3C , lanes 1-5; Figure 7C , lane 1) was obtained. The absence of binding of H. pylori to the sialyl-Le a hexaglycosylceramide ( Figure 3B , lane 8; Figure 7B , lanes 2 and 3) should also be noted.
Discussion
H. pylori has a very narrow host and tissue range and has only been found in connection to gastric cells from humans and monkeys (Dubois et al., 1991) . In the present study, a human gastric adenocarcinoma was used as a model for human gastric epithelium, to obtain sufficient material to allow isolation and structural characterization of potential H. pylori-binding glycosphingolipids. Acidic and neutral glycosphingolipid fractions obtained from the adenocarcinoma were tested for H. pylori-binding activity, and two slow-migrating H. pyloribinding gangliosides were thereby detected. After isolation the binding-active gangliosides were characterized by mass spectrometry, proton NMR, and lectin binding as sialylneolactohexaosylceramide (NeuAcα3Galβ4GlcNAcβ3Galβ4Glc-NAcβ3Galβ4Glcβ1Cer) and sialyl-neolactooctaosylceramide (NeuAcα3Galβ4GlcNAcβ3Galβ4GlcNAcβ3Galβ4GlcNAcβ3-Galβ4Glcβ1Cer). Sialyl-neolactohexaosylceramide has been tentatively identified in normal human gastric epithelium (Teneberg et al., unpublished data) . The structures of the gangliosides isolated from human gastric adenocarcinoma and their H. pylori-binding activity are summarized in Table I . The nonbinding of the GM3 ganglioside and NeuAcα6neo-lactotetraosylceramide, sialyl-Le a hexaglycosylceramide, along with binding to NeuAcα3neolactohexaosylceramide and NeuAcα3neolactooctaocylceramide is in agreement with the NeuAcα3Galβ4GlcNAcβ-epitope previously suggested by Johansson and Miller-Podraza (1998) .
Interestingly, gangliosides with terminal NeuAcα3Gal-β4GlcNAcβ3Galβ4GlcNAcβ sequence are also recognized by the neutrophil-activating protein of H. pylori, HPNAP . However, although it was recently reported that HPNAP is a major immunogen of H. pylori (Satin et al., 2000) , the presence of this protein on the bacterial cell surface has not yet been demonstrated. Further investigations are thus necessary to determine if the HPNAP is the adhesin involved in binding of H. pylori to the sialylated sequences described here.
The normal human gastric epithelium has a low content of sialylated glycoconjugates (Filipe, 1979; Madrid et al., 1990) . However, ablation of parietal cells in transgenic mice leads to an increased proliferation of NeuAcα3Galβ-bearing cells to which H. pylori bind (Syder et al., 1999) . Following binding of H. pylori to NeuAcα3Galβ structures, stimulation of the inflammatory response was observed. This earlier study suggests that binding of H. pylori to sialylated glycoconjugates seems to be intricately connected to the inflammatory response. It can therefore be envisaged that binding by H. pylori to the linear sialylated neolacto series gangliosides described here may act in a similar manner. Infection by H. pylori is persistent, and the ability of the organism to adapt to changes in its environment may be deemed necessary for its survival. In an environment where receptors are appearing and disappearing, the ability of H. pylori to bind to a range of receptors in its environment may be a prerequisite for not just its survival but also the maintenance of persistent infection and the development of gastritis (Syder et al., 1999) .
With respect to binding of H. pylori to the GM3 ganglioside, there are conflicting reports in the literature. Binding by H. pylori to GM3 ganglioside and sulfatide was reported in one study (Saitoh et al., 1991) , but the binding by H. pylori to sulfatide but not to GM3 was later reported by the same group (Kamisago et al., 1996) . Other studies report that binding to GM3 ganglioside by strain NCTC 11637 is occasional (MillerPodraza et al., 1997) or is lost on growth in liquid culture (Kamisago et al., 1996; Miller-Podraza et al., 1996) . During the course of this study, no binding to the GM3 ganglioside was observed in spite of the fact that the bacteria were cultured on solid media. These conflicting findings may in part be explained by poor exposure of this ganglioside on the thin-layer plate surface.
Binding of H. pylori to sialyl-neolactotetraosylceramide has also been reported Johansson and Karlsson, 1998) . However, no binding to the ganglioside with the NeuAc-Hex-HexNAc-Hex-Hex sequence (fraction II), and most likely sialyl-neolactotetraosylceramide, was observed in the present study. H. pylori binds to sialyl-neolactotetraosylceramide when cultured on agar but not in liquid media (Miller-Podraza et al., 1996) . As all strains used in this study were cultured on agar plates, this cannot explain the lack of binding to NeuAc-Hex-HexNAc-Hex-Hex sequence observed. A preferential binding of many strains to terminal NeuAcα3 over NeuAcα6 have been described (Hirmo et al., 1996; Johansson and Miller-Podraza, 1998; Johansson et al., 1999) . An increase in the expression of NeuAcα6-terminated gangliosides in human colonic and liver adenocarcinoma as opposed to the corresponding normal tissue has been reported (Hakamori et al., 1983a,b; Nilsson et al., 1985) . Thus a possible explanation for the nonbinding of H. pylori to fraction II may be that the sequence isolated during the course of this work contains NeuAcα6 instead of NeuAcα3. Due to insufficient material, it was not possible to clarify this point.
The sialyl-Le a -epitope has been detected in lipid extracts from four out of five human gastric adenocarcinomas (Magnani et al., 1982) . In the present study the proton NMR data demonstrated the presence of sialyl-Le a in fraction III. However, no ions indicating a NeuAc-Hex-(Fuc)-HexNAcHex-Hex were found by negative ion FAB-MS. In addition, no binding by the monoclonal antibody CA 19-9 was observed to this fraction. The nondetection of the sialyl-Le a glycosphingolipid by negative ion FAB-MS might be due to the failure of this glycospshingolipid to enter the gas phase during the negative ion FAB-MS experiment. Although no binding by the monoclonal antibody CA 19-9, specific for the sialyl-Le a -epitope, to the total acidic or the isolated fractions from human gastric adenocarcinoma was obtained, binding of the CA 19-9 antibody was instead achieved to the acidic glycosphingolipids of human gallbladder adenocarcinoma and the reference Le a ( Figure 7C ). Although binding of both H. pylori and the monoclonal antibody CA 19-9 to the acidic glycosphingolipids of human gallbladder adenocarcinoma was observed, binding was to different regions ( Figure 7B, lanes 2 and 3) . This, (Xiang et al., 1995; Censini et al., 1996) . Type I strains express both cytotoxinassociated protein (CagA) and vacuolating cytotoxin (VacA) and are more virulent than type II strains, which, by definition, express neither CagA nor VacA cytotoxin. Other strains, including some type I strains, have been shown to express the blood group antigen-binding adhesin (BabA) (Gerhard et al., 1999) . The Lewis b blood group epitope (Fucα2Galβ3(Fucα4)GlcNAcβ) is expressed on human gastric epithelial cells (Borén et al., 1993) and acts as a receptor for H. pylori strains expressing the BabA adhesin but not for strains lacking it (Ilver et al., 1998) . In a recent study, it was demonstrated that H. pylori strains expressing the BabA adhesin in addition to CagA and VacA had high correlation to duodenal ulcer and adenocarcinoma but low correlation to MALT lymphoma and gastritis (Gerhard et al., 1999) . On the other hand, type I strains that were both CagA and VacA positive but BabA negative were associated with only duodenal ulcer but not adenocarcinoma. This illustrates the role that not just strain but also the expression/nonexpression of a particular adhesin play in determining the outcome of infection with H. pylori.
The observed binding in this study by H. pylori strains CCUG 17874 and S-032 to both the crude acidic fraction and to slow migrating gangliosides isolated from this fraction (see Tables I and II) , and the lack of binding as observed for strain CCUG 17875 are in agreement with previously published results that report the binding of strains CCUG 17874 and S-032 to sialic acid-containing glycoconjugates (Hirmo et al., 1996) , while strain CCUG 17875 does not bind sialic acid (Hirmo et al., 1996; Miller-Podraza et al., 1997) . It should also be noted that strain 26695 does not bind the total acidic fraction (see Table II ). This difference in binding may be explained by the expression of different adhesins by the different strains. Because H. pylori strains show a high degree of variability with respect to binding, caution should be exercised when attempting to extrapolate the binding pattern of one strain to the general H. pylori population.
NeuAcα3Galβ4Glcβ-terminated glycoconjugates inhibit the binding of H. pylori to human gastrointestinal adenocarcinoma-derived cell lines (Simon et al., 1997) , and it was recently reported that anti-adhesive therapy with NeuAcα3Galβ4Glcβ in H. pylori-infected Rhesus monkeys gave suppression of infection (Mysore et al., 1999 
Materials and methods
Isolation of glycosphingolipids from human gastric adenocarcinoma
A human gastric adenocarcinoma (dry weight 80 g) was obtained at autopsy, and after lyophilization the tissue was kept at -70°C for several years. Extraction of glycosphingolipids was carried out as previously described (Karlsson, 1987) using chloroform:methanol (2:1 and 9:1, by volume) in a Soxhlet apparatus. The fractions were pooled, subjected to mild alkaline hydrolysis, and dialyzed before separation on a silicic acid column. Acidic and neutral glycosphingolipids were then separated on a DEAE-cellulose column. The neutral glycosphingolipids were acetylated and separated from alkalistable phospholipids on a second silicic acid column. This was followed by deacetylation and dialysis of the neutral glycosphingolipids. Final purification of the total neutral fraction was achieved using DEAE and silicic acid columns. Approximately 500 mg of crude acidic glycosphingolipids and 430 mg of neutral glycosphingolipids was obtained.
The crude total acidic fraction (approximately 480 mg) was acetylated (Handa, 1963) , and initially purified on a silicic acid column. After deacetylation, further separation using an Iatrobeads column (Iatron Laboratories, Tokyo) was carried out, before final purification by HPLC on a Kromosil 5 silica column of length 250 mm, ID 10 mm, and particle size of 5 µm (Phenomenex, Torrance CA) using a linear gradient of chloroform:methanol:water (60:35:8 to 40:40:12, by volume) over 180 min, with a flow rate of 2 ml/min. The 2-ml fractions collected were analyzed by thin-layer chromatography and anisaldehyde staining, and the H. pylori-binding activity was assessed using the chromatogram binding assay. The fractions were pooled according to the mobility on thin-layer chromatograms and their H. pylori-binding activity.
Chemical determinations
The sialic acid content was determined essentially using the resorcinol/HCl method (Svennerholm, 1957) with minor modifications. The absorbance of the upper phase at 620 nm was read. Determination of the sphingosine content of both the neutral and acidic fractions was carried out according to the method of Lauter and Trams (1960) with minor modifications.
Reference glycosphingolipids
The reference glycosphingolipids were isolated and characterized at the Institute of Medical Biochemistry, Göteborg University, Sweden. Structural characterization was performed using proton NMR spectroscopy (Falk et al., 1979a,b,c; Koerner et al., 1983) , mass spectrometry (Samuelsson et al., 
Mass spectrometry
Mass spectra were obtained on a JEOL SX 102A mass spectrometer (JEOL, Tokyo). Negative ion FAB mass spectra were obtained of native gangliosides dissolved in dimethyl sulfoxide using Xe atom bombardment (6 keV), an acceleration voltage of 8 kV or 10 kV, triethanolamine as matrix, and a resolution of 1000.
Proton NMR spectroscopy
1 H-NMR spectra were acquired on a Varian 600 MHz spectrometer at 30°C. The samples were dissolved in dimethyl sulfoxide:D 2 O (98:2, by volume) after deuterium exchange.
